Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Class A common stock, $0.0001 par value per share
-
Shares outstanding
-
94,391,904
-
Total 13F shares
-
63,628,211
-
Share change
-
+7,319,768
-
Total reported value
-
$4,682,588,810
-
Put/Call ratio
-
25%
-
Price per share
-
$73.59
-
Number of holders
-
153
-
Value change
-
+$549,670,471
-
Number of buys
-
111
-
Number of sells
-
30
Institutional Holders of Nuvalent, Inc. - Class A common stock, $0.0001 par value per share (NUVL) as of Q4 2023
As of 31 Dec 2023,
Nuvalent, Inc. - Class A common stock, $0.0001 par value per share (NUVL) was held by
153 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,628,211 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FMR LLC, Paradigm Biocapital Advisors LP, Bain Capital Life Sciences Investors, LLC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., Fairmount Funds Management LLC, STATE STREET CORP, and COMMODORE CAPITAL LP.
This page lists
153
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.